Although GH has been used in female infertility for over thirty years, there is still a lack of guidelines or consensus on the administration regimen of GH, so clinical protocols are always based on the experience of ART centers or individual clinicians, resulting in significant distinctions in the timing and dosage of administration. The gene discussed is GH1; the disease is female infertility.